Deryk Loo

Summary

Publications

  1. ncbi The glycotope-specific RAV12 monoclonal antibody induces oncosis in vitro and has antitumor activity against gastrointestinal adenocarcinoma tumor xenografts in vivo
    Deryk Loo
    Raven Biotechnologies Inc, 1140 Veterans Boulevard, South San Francisco, CA 94080, USA
    Mol Cancer Ther 6:856-65. 2007
  2. ncbi Primary and multipassage culture of human fetal kidney epithelial progenitor cells
    Deryk Loo
    Raven Biotechnologies Inc, South San Francisco, California 94080, USA
    Methods Cell Biol 86:241-55. 2008

Collaborators

Detail Information

Publications2

  1. ncbi The glycotope-specific RAV12 monoclonal antibody induces oncosis in vitro and has antitumor activity against gastrointestinal adenocarcinoma tumor xenografts in vivo
    Deryk Loo
    Raven Biotechnologies Inc, 1140 Veterans Boulevard, South San Francisco, CA 94080, USA
    Mol Cancer Ther 6:856-65. 2007
    ..This preclinical data has led to the initiation of a phase I/IIA clinical study of RAV12 in patients with metastatic or recurrent adenocarcinoma...
  2. ncbi Primary and multipassage culture of human fetal kidney epithelial progenitor cells
    Deryk Loo
    Raven Biotechnologies Inc, South San Francisco, California 94080, USA
    Methods Cell Biol 86:241-55. 2008
    ..2 mM), suggesting that differentiation of the kidney epithelial progenitor culture can be modulated in part by altering the calcium concentration of the medium...